Prescribed by Code: Pharma Marketing in the Age of Clinical Algorithms
Clinical decisions are no longer shaped only by physician experience or pharmaceutical sales conversations. Increasingly, software tools analyze patient data, clinical guidelines, and treatment...
The Rise of the Institutional Buyer: Rethinking Pharma Marketing for Health Systems
Pharmaceutical marketing is changing quickly. For decades, success depended heavily on influencing individual physicians. However, healthcare consolidation has reshaped the buying landscape. Today, large...
The Subscription Reckoning: Can Pharma Market in a Pay-for-Performance World?
The pharmaceutical industry is entering a new commercial era. For decades, drug pricing and market access were largely driven by volume, formulary placement, and...
Creating the Category: How to Market First-in-Class Therapies Without Confusing the Market
What happens when your brand is so innovative that no one quite understands it yet? That is the paradox at the heart of first-in-class...
Launch Order Matters: Designing an International Sequencing Strategy for Maximum Impact
When did launch timing become as important as the product itself? In today’s environment, a thoughtful global launch strategy in pharma no longer assumes...
Measuring Trust in Real Time: Pharma Brand Reputation Analytics
Measuring trust in real time may sound ambitious, yet in 2026 it is quickly becoming a commercial necessity. What we now call pharma brand...
Insurance Isn’t the Only Gatekeeper: Marketing to Employers and Benefits Coalitions
When pharma teams think about access, they often picture payers, PBMs, and formulary negotiations. However, insurance isn’t the only gatekeeper anymore. Today, self-insured employers...
Recruiting at Scale: AI, Ethics, and the Future of Clinical Trial Marketing
Clinical trials no longer compete quietly in the background. Instead, they compete for attention, trust, and speed. A strong clinical trial recruitment marketing strategy...
When Pharma Faces the Spotlight: Marketing Strategy During Political and Legal Scrutiny
When a pharmaceutical company is called before Congress or named in a lawsuit, the spotlight can feel blinding. Headlines spread fast, social media amplifies...
The Saturation Problem: How to Model HCP Channel Fatigue in Omnichannel Campaigns
Pharma marketers often assume that more touchpoints equal more impact. However, does another email, rep visit, or EHR alert truly increase influence—or simply add...
